1. Robert Koch-Institut. Krebs in Deutschland 2011/2012. Gesundheitsberichterstattung des Bundes 2015 [Internet]. 10th ed. Berlin: Robert Koch-Institut; 2015.
http://dx.doi.org/10.17886/rkipubl-2015-004
. Accessed 22 Nov 2016.
2. World Health Organization. International statistical classification of diseases and related health problems. 10th ed. Geneva: World Health Organization; 2011.
3. Sant M, Allemani C, Tereanu C, Angelis RD, Capocaccia R, Visser O, et al. Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project. Blood. 2010;116:3724–34.
4. Joshi M, Sheikh H, Abbi K, Long S, Sharma K, Tulchinsky M, et al. Marginal zone lymphoma: old, new, targeted, and epigenetic therapies. Ther Adv Hematol. 2012;3:275–90.
5. National Institute for Clinical Excellence. Improving outcomes in haematological cancer-the manual. Department of Health London; 2003.
https://www.nice.org.uk/guidance/ng47/evidence/improving-outcomes-in-haematological-cancers-the-manual-2487893581
. Accessed 22 Nov 2016.